Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

n/a
Abstract Title:

Restoring the activity of the antibiotic aztreonam using the polyphenol epigallocatechin gallate (EGCG) against multidrug-resistant clinical isolates of.

Abstract Source:

J Med Microbiol. 2019 Aug 16. Epub 2019 Aug 16. PMID: 31419210

Abstract Author(s):

Jonathan W Betts, Michael Hornsey, Paul G Higgins, Kai Lucassen, Julia Wille, Francisco J Salguero, Harald Seifert, Roberto M La Ragione

Article Affiliation:

Jonathan W Betts

Abstract:

.is an important Gram-negative pathogen that is intrinsically multidrug-resistant (MDR) and frequently associated with healthcare-associated outbreaks. With increasing resistance to antibiotics and with very few novel drugs under development, clinicians often use combinations to treat critically ill patients.. The aim of this study was to evaluate the ability of epigallocatechin (EGCG) to restore the activity of aztreonam against clinical MDR strains of.. Checkerboard and time-kill kinetic assays were performed to assess synergyand themodel of infection was used to test the efficacy of the combination. Accumulation assays were performed to gain insight into the mechanism of action.. The results demonstrate that synergy between aztreonam and EGCG exists [fractional inhibitory concentration indices (FICIs) 0.02-0.5], with the combination affording significantly (=<0.05) enhanced bacterial killing, with a>3 logreduction in colony-forming units mlat 24 h. EGCG was able to restore susceptibility to aztreonam to a level equal to or below the breakpoint set by the European Committee for Antimicrobial Susceptibility Testing. In, the combination was superior to monotherapy, with increased larval survival observed (94 % vs≤63 %). We also demonstrated the relatively low toxicity of EGCG to human keratinocytes andlarvae. Accumulation assay data suggest that the mechanism of synergy may be due to EGCG increasing the uptake of aztreonam.. EGCG was able to restore the activity of aztreonam against MDR. The data presented support further evaluation of the aztreonam-EGCG combination and highlight its potential for use in clinical medicine.

Study Type : In Vitro Study

Print Options


Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2019 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.